SINGLETO2 THERAPEUTICS
SingletO2 Therapeutics creates new treatments for periodontal disease using singlet oxygen. The company was founded in 2015 and is headquartered in New Providence, New Jersey.
SINGLETO2 THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2015-01-01
Address:
New Providence, New Jersey, United States
Country:
United States
Website Url:
http://www.singleto2.com
Status:
Active
Total Funding:
256 K USD
Technology used in webpage:
LetsEncrypt IPv6 1and1 1and1 Email Solutions Zoho Sites
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Current Employees Featured
Alan Lyons
Alan Lyons COO @ SingletO2 Therapeutics COO 2016-04-01
Alexander Greer
Alexander Greer CTO @ SingletO2 Therapeutics CTO
Founder
Alan Lyons
Alexander Greer
Investors List
National Science Foundation
National Science Foundation investment in Grant - SingletO2 Therapeutics
Official Site Inspections
http://www.singleto2.com
- Host name: 74-208-236-20.elastic-ssl.ui-r.com
- IP address: 74.208.236.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Loading ...